We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Senior Plc | LSE:SNR | London | Ordinary Share | GB0007958233 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.00 | -1.23% | 160.00 | 160.00 | 161.20 | 166.40 | 159.20 | 166.40 | 741,336 | 16:35:28 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Indl, Coml Machy, Equip, Nec | 963.5M | 31.1M | 0.0751 | 21.44 | 666.38M |
From Apr 2019 to Apr 2024
TIDMSNR
RNS Number : 7649N
Senior PLC
28 October 2016
Pursuant to Listing Rule 9.6.14 (2), this is to notify that effective 1 November 2016, Giles Kerr, an independent non-executive Director of Senior plc, is appointed as a non-executive director of Adaptimmune Therapeutics plc (Nasdaq: ADAP) (www.adaptimmune.com).
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDNMPBBTMBTTBLF
(END) Dow Jones Newswires
October 28, 2016 07:30 ET (11:30 GMT)
1 Year Senior Chart |
1 Month Senior Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
